PDUFA III “Good Review Management Principles” To Stress Early Action

Related Content

FDA “Independent Consultant” Guidance Implements PDUFA III Provision

FDA “Independent Consultant” Guidance Implements PDUFA III Provision

FDA Has “Issues” With NDAs; Half Of 74-Day Letters Note Application Flaws

FDA Developing Reviewer Communications Policy; Draft Expected This Year

CDER Review “Consistency” Is One Theme Of FDA Reorganization

PDUFA III Implementation Begins: FDA Working Groups Under Way

CBER Lot Release Requirement Should Be Eliminated – PhRMA

PDUFA III: Bioterrorism Conference May Be Path To Clean Bill, Tauzin Says

Industry Response Time Is Contributing To Slower Drug Approvals, FDA Says

Pfizer, PhRMA See Signs Of Drug Approval "Slowdown" At FDA